C CATALYST PHARMACEUTICALS INC
| Market Cap | $3.03B |
| P/E Ratio | 14.70 |
| Forward P/E | 7.92 |
| Dividend Yield | — |
| Beta | 0.66 |
| 52W Range | $19.13 - $26.31 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Biotechnology |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Terry Smith Fundsmith LLP | 0.46% | $78.51M | 3,363,807 | — |
Insider Trading
| Insider Name of the company insider who made the trade 6 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Harper Molly | Sale | 4,473 | $23.73 | $106.16K | 12 Dec 2025 | 16 Dec 2025 |
| Harper Molly | Sale | 15,527 | $23.20 | $360.20K | 12 Dec 2025 | 16 Dec 2025 |
| Harper Molly | Sale | 6,746 | $23.06 | $155.56K | 12 Dec 2025 | 16 Dec 2025 |
| Del Carmen JeffreyChief Commercial Officer | Sale | 10,983 | $23.33 | $256.24K | 26 Nov 2025 | 28 Nov 2025 |
| Carmen Jeffrey DelChief Commercial Officer | Sale | 10,983 | $23.33 | $256.24K | 26 Nov 2025 | 28 Nov 2025 |
| Elsbernd BrianChief Compliance/Legal Officer | Sale | 40,000 | $22.70 | $908.00K | 12 Nov 2025 | 14 Nov 2025 |
Frequently Asked Questions
What is CPRX stock price today?
CATALYST PHARMACEUTICALS INC (CPRX) is currently trading at $24.69. The stock has a 52-week range of $19.13 to $26.31 and a market capitalization of $3.03B.
Is CPRX a good stock to buy in 2026?
CATALYST PHARMACEUTICALS INC has a P/E ratio of 14.7 (forward P/E: 7.9), a dividend yield of none, and 1-year performance of +2.4%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling CPRX stock?
There have been 6 insider transactions for CPRX in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has CPRX stock performed over the past year?
CATALYST PHARMACEUTICALS INC (CPRX) has returned +2.4% over the past 12 months. The stock traded between $19.13 and $26.31 during this period, and is currently at $24.69.
Which hedge funds own CPRX (CATALYST PHARMACEUTICALS INC)?
1 tracked hedge funds currently hold CPRX in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is CPRX's market cap and valuation?
CATALYST PHARMACEUTICALS INC (CPRX) has a market capitalization of $3.03B. The trailing P/E ratio is 14.7 and forward P/E is 7.9. The stock is classified in the Healthcare sector.
What is CPRX's revenue and profitability?
CATALYST PHARMACEUTICALS INC reported revenue of $588.99M with net income of $214.33M and a profit margin of 0.36%. The stock has a beta of 0.66.
What sector is CPRX in and who are its biggest institutional holders?
CATALYST PHARMACEUTICALS INC (CPRX) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.